Background
Congenital cardiac surgery for individuals with Down Syndrome (DS) has historically occurred at reduced frequency. Little data is available regarding long-term post congenital cardiac surgical outcomes. Limited sample sizes and clinical heterogeneity require a pooled analysis approach.
Objective
To compare long-term outcomes post-congenital heart surgery between adults with and without Down Syndrome.
Methods
Databases (Medline, Embase and Pubmed) were searched utilising terms related to DS and congenital heart disease.
Studies that enrolled adults (>18 years) with operated congenital heart disease and compared long term outcomes with respect to DS presence were included. All study designs were included, but those with limited/peri-operative follow-up, non-English texts, case studies and literature reviews excluded.
Blinded screening, data extraction and quality assessment were independently conducted by two reviewers. QUIPS criteria were used for risk of bias analysis. Both random and fixed effects models were used for meta-analysis.
Results
Twenty-three studies (n = 10466) were included. Risk of bias was frequently high due to unblinded retrospective study designs and analyses limited in adjustment for other prognostic factors.
Meta-analysis demonstrated no effect of DS on long-term mortality (HR 0.86, 95% CI 0.6-1.23), to a maximum described follow-up of 38 years. Lower cardiac reoperation risk (HR 0.6, 95% CI 0.46-0.78) for individuals with DS was found on pooled analysis. Meta-analysis was limited by between-study variation.
Conclusions
DS does not affect post congenital cardiac surgical survival in adulthood. Reduced reoperation may reflect challenges in assessing functional and symptomatic status and/or concerns regarding perceived reoperation difficulties or likely benefits.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.